The promising potential of thérapie par cellules souches has given rise to initially encouraging clinical results. While doctors in North America and Western Europe continue to study thérapie par cellules souches, rigorously evaluating its potential benefits, necessity triggered application of this science in clinical practice in Ukraine almost 20 twenty years ago. Nearly a million people in the Kiev area alone experienced adverse health effects when radioactive dust settled across Ukraine following the nuclear reactor explosion at Chernobyl in April 1986. Faced with treating patients suffering from conditions ranging from diabetes to blood anemia and cancer, the Ukrainian government began funding new research into repairing tissue and blood cells that would produce results quickly. Doctors turned to adult thérapie par cellules souches, and they claim to have been successfully treating patients there since the Chernobyl disaster. Scientists in other countries are skeptical about this success because there are no published random clinical trials – the gold standard of medical research – regarding the positive or negative effects of thérapie par cellules souches. Many countries have banned some forms of stem cell research, while scientists in other countries strive to become leaders in this controversial area of exploration.
Thérapie par cellules souches
Thérapie par cellules souches pour le foie
Les patients atteints de cirrhose décompensée doivent majoritairement opter pour une transplantation hépatique, mais la disponibilité limitée des donneurs d'organes et leur coût élevé entraînent une mortalité élevée sur les listes d'attente . Les cellules souches de notre propre corps aident Lire la suite…